New Path for ALS Drug Discovery Thursday, January 07, 2016 For the first time, scientists pin down the structure of toxic clumps of a protein associated with a large number of ALS cases, opening new avenues in the pursuit of drugs to stem the disease.Complix Launches Strategic Collaboration with Merck Thursday, January 07, 2016 Complix to receive upfront fees, research funding, and milestone payments.Takeda, Enterome Enter Drug Discovery Collaboration Thursday, January 07, 2016 Takeda and Enterome have announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including inflammatory bowel diseases (e.g. ulcerative colitis) and motility disorders (e.g. irritable bowel syndrome).Flu Virus Hijacking Tactics Revealed Thursday, January 07, 2016 Scientists at Imperial College London have discovered how flu viruses 'hijack' cell machinery when they infect the body. Sanofi, Global Genomics Group Partner Wednesday, January 06, 2016 Global Genomics Group ("G3") announced that it has entered into a research collaboration with Sanofi to identify new signaling pathways and targets involved in the etiology of coronary artery disease.
Study Shows High Frequency of Spontaneous Mutation in Ebola Virus Wednesday, January 06, 2016 Mutation rate of Ebola virus could prove a useful therapy.KineMed, Pfizer Launch Collaboration Tuesday, January 05, 2016 KineMed has announced that it has entered into a strategic collaboration with Pfizer to discover and develop novel proprietary biomarkers in various fields of unmet medical need. BioTime Spins Off OncoCyte Tuesday, January 05, 2016 OncoCyte Corporation a company focused on non-invasive cancer diagnostics, announced that its common stock is now trading on the NYSE MKT under the symbol "OCX." STING Protein Could be Used for Cancer Diagnosis Tuesday, January 05, 2016 A new study reports on a key finding about the immune system’s response to tumor development following studies on colorectal cancer.